Fredrick M. Wigley

Johns Hopkins University — United States

Medicine · Health Sciences

83h-index24.3kcitations354works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Sclerosis and Related Diseases(264), Dermatologic Treatments and Research(69), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(61), Inflammatory Myopathies and Dermatomyositis(52), Mast cells and histamine(50)

Publications348 total

Abstract 4364326: Right Atrial Longitudinal Strain Phenotypes in Patients with Systemic Sclerosis
Circulation·2025
Abstract 4364054: Prevalence and Clinical Correlates of Valvular Abnormalities in Systemic Sclerosis: Associations with Pulmonary Vascular and Disease Severity
Circulation·2025
Abstract 4364753: Refining Atherosclerotic Risk Prediction in Patients with Systemic Sclerosis: Association with Uric Acid and the Creation of a Novel Scleroderma-Atherosclerotic Cardiovascular Disease Risk (ScleroRisk) Assessment Model
Circulation·2025
Systemic Sclerosis–Associated Myopathy in a Large Single‐Center Cohort: Autoantibody Profiles, Histologic Features, and Independent Risk of Death
Arthritis Care & Research·2025
Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic Sclerosis
Arthritis & Rheumatology·2025
The Effect of Pulmonary Function Test Reference Equations on Classification of Restrictive Lung Disease Severity in Systemic Sclerosis
Arthritis Care & Research·2025
Refining Risk Prediction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension
Journal of the American Society of Echocardiography·2025· 1 cited
18F-NaF PET/CT identifies muscular and subcutaneous calcifications in both dermatomyositis- and systemic sclerosis-related calcinosis
Frontiers in Nuclear Medicine·2025Open Access
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications
Current Cardiology Reports·2025· 5 citedOpen Access
Abstract 4143487: Refining Risk Prediction in Systemic Sclerosis Pulmonary Arterial Hypertension
Circulation·2024
Abstract 4147678: Distinct Echocardiographic Signatures Predict Mortality in Scleroderma Pulmonary Vascular Disease
Circulation·2024
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis
Lara D. Veeken·2024· 13 citedOpen Access
Is there evidence for an autoimmune response to components of the TGF-b signalling pathway in scleroderma?
Clinical and Experimental Rheumatology·2024Open Access
Racial variability in immune responses only partially explains differential systemic sclerosis disease severity
Annals of the Rheumatic Diseases·2024· 3 citedOpen Access
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
Seminars in Arthritis and Rheumatism·2024· 6 citedOpen Access
The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck Cancer
Practical Radiation Oncology·2024· 2 citedOpen Access
Issue Information
Arthritis & Rheumatology·2024· 1 citedOpen Access
Issue Information
Arthritis & Rheumatology·2024Open Access
Overlooked Manifestations
2024
Drug Therapy
2024
page 1 of 18Next →

Frequent Co-authors

Maureen D. Mayes(14), Barbara White(12), Virginia Steen(12), Laura K. Hummers(11), James R. Seibold(10), John Varga(9), Thomas A. Medsger(9), Philip J. Clements(8), Robert A. Wise(8), David H. Collier(8), Richard M. Silver(7), Robert W. Simms(7), Naomi F. Rothfield(7), Stephen C. Mathai(7), Paul M. Hassoun(7), Daniel E. Fürst(7), Reda E. Girgis(6), Peter A. Merkel(6), Ami A. Shah(6), Larry W. Moreland(6)